+

WO2001098747A3 - Fixation d'agoniste/antagoniste a des recepteurs couples a la proteine g - Google Patents

Fixation d'agoniste/antagoniste a des recepteurs couples a la proteine g Download PDF

Info

Publication number
WO2001098747A3
WO2001098747A3 PCT/US2001/019871 US0119871W WO0198747A3 WO 2001098747 A3 WO2001098747 A3 WO 2001098747A3 US 0119871 W US0119871 W US 0119871W WO 0198747 A3 WO0198747 A3 WO 0198747A3
Authority
WO
WIPO (PCT)
Prior art keywords
binding
agonist
protein
coupled receptors
molecular
Prior art date
Application number
PCT/US2001/019871
Other languages
English (en)
Other versions
WO2001098747A2 (fr
Inventor
Zdzislaw Salamon
Scott Cowell
Victor J Hruby
Gordon Tollin
Original Assignee
Univ Arizona
Zdzislaw Salamon
Scott Cowell
Victor J Hruby
Gordon Tollin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Arizona, Zdzislaw Salamon, Scott Cowell, Victor J Hruby, Gordon Tollin filed Critical Univ Arizona
Priority to JP2002504459A priority Critical patent/JP2004507716A/ja
Priority to AU2001270046A priority patent/AU2001270046A1/en
Priority to EP01948579A priority patent/EP1295120A2/fr
Priority to CA002413081A priority patent/CA2413081A1/fr
Publication of WO2001098747A2 publication Critical patent/WO2001098747A2/fr
Publication of WO2001098747A3 publication Critical patent/WO2001098747A3/fr

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366Apparatus specially adapted for solid-phase testing
    • G01N33/54373Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Procédé servant à caractériser les propriétés biophysiques de récepteurs couplés à la protéine G en réponse à leur fixation par des ligands. On a effectué des investigations sur le récepteur de δ-opioïdes cloné humain immobilisé dans une bicouche lipidique supportée par un solide au moyen d'un procédé mettant en application la spectroscopie par résonance de guides d'ondes au plasmon couplés (CPWR). L'invention présente un procédé extrêmement sensible permettant de contrôler directement les modifications de densité de masse, de conformation et d'orientation moléculaire apparaissant dans des couches minces anisotropes et de déterminer directement des constantes de fixation. Bien que la fixation à la fois de l'agoniste et de l'antagoniste au récepteur provoque des augmentations de l'ordonnancement moléculaire à l'intérieur de la membrane protéolipidique, seule la fixation de l'agoniste induit une augmentation de l'épaisseur et de la densité du regroupement moléculaire de la membrane (10). Ceci constitue un procédé servant à effectuer une distinction entre la fixation de l'agoniste et celle de l'antagoniste.
PCT/US2001/019871 2000-06-22 2001-06-21 Fixation d'agoniste/antagoniste a des recepteurs couples a la proteine g WO2001098747A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2002504459A JP2004507716A (ja) 2000-06-22 2001-06-21 G蛋白質−結合レセプタのアゴニスト及びアンタゴニストのリガンドを区別する方法
AU2001270046A AU2001270046A1 (en) 2000-06-22 2001-06-21 Agonist versus antagonist binding to g protein-coupled receptors
EP01948579A EP1295120A2 (fr) 2000-06-22 2001-06-21 Fixation d'agoniste/antagoniste a des recepteurs couples a la proteine g
CA002413081A CA2413081A1 (fr) 2000-06-22 2001-06-21 Fixation d'agoniste/antagoniste a des recepteurs couples a la proteine g

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21357500P 2000-06-22 2000-06-22
US60/213,575 2000-06-22

Publications (2)

Publication Number Publication Date
WO2001098747A2 WO2001098747A2 (fr) 2001-12-27
WO2001098747A3 true WO2001098747A3 (fr) 2002-04-11

Family

ID=22795635

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/019871 WO2001098747A2 (fr) 2000-06-22 2001-06-21 Fixation d'agoniste/antagoniste a des recepteurs couples a la proteine g

Country Status (5)

Country Link
EP (1) EP1295120A2 (fr)
JP (1) JP2004507716A (fr)
AU (1) AU2001270046A1 (fr)
CA (1) CA2413081A1 (fr)
WO (1) WO2001098747A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030006192A1 (en) * 1998-02-23 2003-01-09 Irving Wainer Immobilized G-protein coupled receptors on liquid chromatography stationary phases and use thereof for on-line screening
US7678539B2 (en) * 2000-08-10 2010-03-16 Corning Incorporated Arrays of biological membranes and methods and use thereof
US20160334395A1 (en) * 2014-01-21 2016-11-17 Nanyang Technological University Hydration layer/lipid bilayer structures

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5991448A (en) * 1994-10-28 1999-11-23 Oki Electric Industry Co., Ltd. Image encoding and decoding method and apparatus using edge synthesis and inverse wavelet transform

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5991448A (en) * 1994-10-28 1999-11-23 Oki Electric Industry Co., Ltd. Image encoding and decoding method and apparatus using edge synthesis and inverse wavelet transform

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BEIRI ET AL.: "Micropatterned immobilization of G protein-coupled receptor: and direct detection of G protein activation", NAT. BIOTECHNOL., vol. 17, November 1999 (1999-11-01), pages 1105 - 1108, XP002183971 *
SALAMON ET AL.: "Coupled plasmon-waveguide resonators: A new spectroscopis tool for probing proteolipid film structure and properties", BIOPHYS. J., vol. 75, October 1998 (1998-10-01), pages 1874 - 1885, XP002906545 *
SLEPAK V.Z.: "Application of surface plasmon resonance for analysis of protein-protein interactions in the G protein-mediated signal transduction pathway", J. MOL. RECOGNIT., vol. 13, January 2000 (2000-01-01), pages 20 - 26, XP002906134 *

Also Published As

Publication number Publication date
CA2413081A1 (fr) 2001-12-27
WO2001098747A2 (fr) 2001-12-27
JP2004507716A (ja) 2004-03-11
EP1295120A2 (fr) 2003-03-26
AU2001270046A1 (en) 2002-01-02

Similar Documents

Publication Publication Date Title
WO2001077172A3 (fr) Recepteurs connus couples a la proteine g non endogenes a activation constitutive
WO2001036471A3 (fr) Versions endogenes et non-endogenes de recepteurs couples a la proteine g humaine
EP1477880A3 (fr) Navigateur Sécurisé
MX2009005963A (es) Anticuerpos humanos contra el ligando 4 de tipo delta humano.
WO2003040309A3 (fr) Peptides jouant a la fois de role d'agonistes du recepteur glp-1 et d'antagonistes du recepteur de glucagon et leurs methodes d'utilisation pharmacologique
WO2004104759A3 (fr) Procedes et systeme de partage d'images sur un reseau
HK1107012A1 (en) Long acting sustained-release formulation containing dopamine receptor agonist and the preparation method thereof
WO2001098747A3 (fr) Fixation d'agoniste/antagoniste a des recepteurs couples a la proteine g
AU3080499A (en) Analgesic combination comprising nmda receptor antagonists and narcotic analgesics
CA2019559A1 (fr) Recepteurs bispecifiques et oligospecifiques mono- et oligovalents, preparation et utilisation
CA2305810A1 (fr) Procedes d'analyse de l'activite de recepteurs et produits de recombinaison utiles dans de tels procedes
WO1996029315A3 (fr) Derives d'imidazole (ant)agonistes du recepteur h3 de l'histamine
WO1998051329A1 (fr) Remede contre la cachexie
PT1133559E (pt) Receptor acoplato a proteina g orfao humano, rup3
GB2427945A (en) Data compression methods and systems
EP2579496A3 (fr) Affichage d'un élément de sécurité avec une fenêtre de navigateur
WO2003025137A3 (fr) Recepteurs du gout sucre
WO2001015014A3 (fr) Systeme et procede de visualisation anticipee d'un reseau
WO2005091839A3 (fr) Procédés et appareils permettant d'annuler des interrogations
TW200821208A (en) Sensor device
WO2002100350A3 (fr) Ligands des recepteurs de dopamine et procedes therapeutiques correspondants
WO2002059082A8 (fr) Ligands d'agoniste et d'antagoniste du recepteur de serotonine a substitution aryle et aminoaryle
CN100375527C8 (zh) 内容选择中的改进以及与内容选择相关的改进
WO2003098397A3 (fr) Procede et appareil de determination de l'epaisseur et de la composition d'une couche par evaluation ellipsometrique
Ichikawa et al. In vitro inhibitory effects of J-113397 on nociceptin/orphanin FQ-stimulated [35S] GTPγS binding to mouse brain

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 2413081

Country of ref document: CA

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2002 504459

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 2001948579

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001948579

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2001948579

Country of ref document: EP

点击 这是indexloc提供的php浏览器服务,不要输入任何密码和下载